Showing results (221-230 of 330) with videos related to
Sort By:
Pageof 33
Plos One|April 10, 2008
Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS studyDaisuke Matsuzawa, Takayuki Obata, Yukihiko Shirayama, et al.Journal of Psychopharmacology (Oxford, England)|July 3, 2023
Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practiceFumiaki Yamasaki, Nobuhisa Kanahara, Yusuke Nakata, et al.Archives of General Psychiatry|June 11, 2003
Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophreniaKenji Hashimoto, Takeshi Fukushima, Eiji Shimizu, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 21, 2011
Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese populationTaro Kishi, Tomo Okochi, Tsuyoshi Kitajima, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 28, 2005
Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PETTetsuya Shiraishi, Tatsuya Kikuchi, Kiyoshi Fukushi, et al.Brain Imaging and Behavior|October 13, 2016
Relationship between symptom dimensions and brain morphology in obsessive-compulsive disorderMotohisa Hirose, Yoshiyuki Hirano, Kiyotaka Nemoto, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 27, 2004
Association between the brain-derived neurotrophic factor 196G/A polymorphism and eating disordersHiroki Koizumi, Kenji Hashimoto, Kanako Itoh, et al.Schizophrenia Research. Cognition|August 8, 2020
Autistic traits and cognitive profiles of treatment-resistant schizophreniaYusuke Nakata, Nobuhisa Kanahara, Atsushi Kimura, et al.Journal of Clinical Psychopharmacology|August 29, 2012
A randomized, double-blind, placebo-controlled trial of fluvoxamine in patients with schizophrenia: a preliminary studyTomihisa Niitsu, Mihisa Fujisaki, Akihiro Shiina, et al.Biological Psychiatry|July 31, 2007
High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503Masatomo Ishikawa, Kiichi Ishiwata, Kenji Ishii, et al.Pageof 33